168 related articles for article (PubMed ID: 36240831)
1. Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020.
Murhekar MV; Gupta N; Hasan AZ; Kumar MS; Kumar VS; Prosperi C; Sapkal GN; Thangaraj JWV; Kaduskar O; Bhatt V; Deshpande GR; Thankappan UP; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma S; Sarmah NP; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Shrivastava AK; Chonker SK; Tilekar B; Tandale BV; Ahmad M; Sangal L; Winter A; Mehendale SM; Moss WJ; Hayford K
Lancet Glob Health; 2022 Nov; 10(11):e1655-e1664. PubMed ID: 36240831
[TBL] [Abstract][Full Text] [Related]
2. Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
Thangaraj JWV; Prosperi C; Kumar MS; Hasan AZ; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sarmah NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murherkar MV
PLoS One; 2024; 19(3):e0297385. PubMed ID: 38551928
[TBL] [Abstract][Full Text] [Related]
3. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
[TBL] [Abstract][Full Text] [Related]
5. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ
Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529
[TBL] [Abstract][Full Text] [Related]
6. Measles and rubella IgG seroprevalence in persons 6 month-35 years of age, Mongolia, 2016.
Nogareda F; Gunregjav N; Sarankhuu A; Munkhbat E; Ichinnorov E; Nymadawa P; Wannemuehler K; Mulders MN; Hagan J; Patel MK
Vaccine; 2020 May; 38(26):4200-4208. PubMed ID: 32381479
[TBL] [Abstract][Full Text] [Related]
7. Experiences of sharing results of community based serosurvey with participants in a district of Maharashtra, India.
Salvi N; Itta KC; Lachyan A; Hasan AZ; Prosperi C; Kumar MS; Wesley Vivian Thangaraj J; Kaduskar O; Bhatt V; Sapkal GN; Murhekar M; Gupta N; Mehendale S; Hayford K; Moss WJ; Chauhan S; Kulkarni R
PLoS One; 2022; 17(8):e0271920. PubMed ID: 35925959
[TBL] [Abstract][Full Text] [Related]
8. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling.
Hachiya M; Vynnycky E; Mori Y; Do HT; Huynh MK; Trinh LH; Nguyen DD; Tran NAT; Hoang TT; Hoang HHT; Vo NDT; Le TH; Ichimura Y; Miyano S; Okawa S; Thandar MM; Yokobori Y; Inoue Y; Mizoue T; Takeda M; Komada K
Int J Infect Dis; 2024 Jul; 144():107053. PubMed ID: 38641317
[TBL] [Abstract][Full Text] [Related]
9. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
Carcelen AC; Mutembo S; Matakala KH; Chilumba I; Mulundu G; Monze M; Mwansa FD; Moss WJ; Hayford K
Am J Trop Med Hyg; 2021 May; 104(6):2229-2232. PubMed ID: 33939639
[TBL] [Abstract][Full Text] [Related]
10. Measles immunity gaps among children and adolescents with HIV in Zambia despite high measles vaccination and antiretroviral therapy coverage.
Mutembo S; Yang Y; Carcelen A; Winter AK; Mwansa FD; Chilumba I; Mutale I; Chongwe G; Monze M; Mulundu G; Nkamba H; Mulenga L; Hayford K; Moss WJ
AIDS; 2023 Nov; 37(13):2021-2029. PubMed ID: 37418463
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of Dried Blood Spots Collected on HemaSpot HF Devices Compared to Venous Blood Specimens To Estimate Measles and Rubella Seroprevalence.
Prosperi C; Kaduskar O; Bhatt V; Hasan AZ; Vivian Thangaraj JW; Kumar MS; Sabarinathan R; Kumar S; Duraiswamy A; Deshpande GR; Padinjaremattathil Thankappan U; Chauhan SL; Kulkarni RN; Bansal AK; Chaaithanya IK; Salvi NR; Sharma S; Moss WJ; Sangal L; Gupta N; Murherkar MV; Mehendale SM; Sapkal GN; Hayford K
mSphere; 2021 Aug; 6(4):e0133020. PubMed ID: 34259557
[TBL] [Abstract][Full Text] [Related]
12. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
[TBL] [Abstract][Full Text] [Related]
13. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
Tohme RA; François J; Wannemuehler K; Magloire R; Danovaro-Holliday MC; Flannery B; Cavallaro KF; Fitter DL; Purcell N; Dismer A; Tappero JW; Vertefeuille JF; Hyde TB
Trop Med Int Health; 2014 Sep; 19(9):1105-15. PubMed ID: 25041586
[TBL] [Abstract][Full Text] [Related]
14. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
Matter L; Germann D; Bally F; Schopfer K
Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
[TBL] [Abstract][Full Text] [Related]
15. Measles and rubella immunity in the population of Bhutan, 2017.
Wangchuk S; Nogareda F; Tshering N; Khandu L; Pelden S; Wannemuehler K; Wangdi S; Wangchuk U; Mulders M; Tamang T; Patel MK
Vaccine; 2019 Oct; 37(43):6463-6469. PubMed ID: 31500970
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India.
Gupta M; Tripathy JP; Verma M; Singh MP; Kaur R; Ratho RK; Kumar R
Indian J Med Res; 2019 Mar; 149(3):396-403. PubMed ID: 31249206
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
[TBL] [Abstract][Full Text] [Related]
18. Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study.
Motaze NV; Makhathini L; Smit SB; Adu-Gyamfi CG; Fortuin M; Wiysonge CS; Suchard SM
Hum Vaccin Immunother; 2020 Nov; 16(11):2656-2662. PubMed ID: 32298204
[No Abstract] [Full Text] [Related]
19. Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.
Danovaro-Holliday MC; Rhoda DA; Lacoul M; Prier ML; Gautam JS; Pokhrel TN; Dixit SM; Rajbhandari RM; Bose AS
BMC Public Health; 2022 Feb; 22(1):221. PubMed ID: 35114969
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign.
Honarvar B; Moghadami M; Moattari A; Emami A; Odoomi N; Bagheri Lankarani K
PLoS One; 2013; 8(1):e55043. PubMed ID: 23383049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
